More tools:Markets·Screener·Research·Chat

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD) Financial Statements

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares
SIC 5122 · WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
FIGI AK-46976230C7
XNAS · usd
0.13▼ 0.00 (-0.31%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.13
Day's Range0.12 – 0.13
52-Week Range0.12 – 1.82
Volume447.3K
Avg Volume3.8M
Share Statistics
Shares Outstanding
Employees27
ExchangeXNAS
Listed2025-01-15
Share count as of March 31, 2026
Loading Income Statement…
Key questions about Cellyan Biotechnology Co., Ltd Class A Ordinary Shares (HKPD)
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Market Cap?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Market Cap is $2.1M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Enterprise Value?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Enterprise Value is $2.8M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Price / Sales?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Price / Sales is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / Revenue?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / Revenue is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / EBITDA?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Revenue (TTM)?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Revenue (TTM) is $13.4M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Net Income (TTM)?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Net Income (TTM) is -$1.1M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA is -$2.3M, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Diluted EPS (TTM)?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's Diluted EPS (TTM) is -0.07, based on as-reported figures from SEC (XBRL) filings.
What is Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA Margin?
Cellyan Biotechnology Co., Ltd Class A Ordinary Shares's EBITDA Margin is -17.2%, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Mar 31, 2025Mar 31, 2024Mar 31, 2023
Profit or loss [abstract]
Revenues
Cost of revenues
Gross profit
Other income
Operating expenses:
Selling, general and administrative expenses
Other gains (losses), net
Total operating expenses
Operating (loss)/profit
Financial income
Finance costs
Finance costs, net
(Loss)/profit before income taxes
Income tax expense
Net (loss)/profit for the year
(Loss)/profit attributable to owners of the Company
Other comprehensive loss
Foreign currency translation adjustments
Comprehensive (loss)/income attributable to the Company’s shareholders
Earnings per share
Basic (in Dollars per share)
Diluted (in Dollars per share)